AIA Blog

Status Update on the Genetic Testing Study

From: Janet Gongola, Patent Reform Coordinator

Under Section 27 of the America Invents Act, the USPTO is required to study effective ways to provide independent, confirming genetic diagnostic test activity where gene patents and exclusive licensing for primary genetic diagnostic tests exist.  To complete this study, the agency held two hearings and received a number of written comments from the public. As of Friday, June 15, 2012, the USPTO is in the process of finalizing its Genetic Testing report through an intra-agency clearance process. Because of this, the agency has alerted Congress that it will not be able to deliver the report on June 16, 2012, the due date required by the AIA.  The agency will deliver its report as soon as possible once this process is complete.

Posted at 12:00AM Jun 16, 2012 in Studies and Reports  |